JP2007210933A - Therapeutic agent for hay fever by chinese drug recipe - Google Patents

Therapeutic agent for hay fever by chinese drug recipe Download PDF

Info

Publication number
JP2007210933A
JP2007210933A JP2006031908A JP2006031908A JP2007210933A JP 2007210933 A JP2007210933 A JP 2007210933A JP 2006031908 A JP2006031908 A JP 2006031908A JP 2006031908 A JP2006031908 A JP 2006031908A JP 2007210933 A JP2007210933 A JP 2007210933A
Authority
JP
Japan
Prior art keywords
component
components
hay fever
chemical
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006031908A
Other languages
Japanese (ja)
Other versions
JP4637030B2 (en
Inventor
Yoichiro Ebe
洋一郎 江部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2006031908A priority Critical patent/JP4637030B2/en
Publication of JP2007210933A publication Critical patent/JP2007210933A/en
Application granted granted Critical
Publication of JP4637030B2 publication Critical patent/JP4637030B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide a therapeutic agent for hay fever caused by INKYO constitution (physical constitution with lack of body fluid, e.g., emaciated constitution). <P>SOLUTION: In the therapeutic agent, a JIIN component (a component for treating symptoms caused by lack of body fluid) comprises at least one species of crude drugs selected from dried roots of Rehmannia glutinosa, Scrophularia ningpoensis Hwmsl., Paeonia lactiflora, Discireae rhizoma, Ophiopongonis tuber, Glehnia littoralis Fr. Schmidt. ex Miq., Cornus officinalis and Achyranthis Radix., a SENYO component (a component for treating head ache, vertigo and the like caused by abnormal rising of activity in the liver) comprises at least one species of crude drugs selected from Red hematite, Carina and oyster, a SEINETSU component (an antifebrile component) comprises at least one species of crude drugs selected from Anemarrhenae rhizoma and gypsum, a SOKUFU component (a component for treating symptoms caused by central nervous system disorders) comprises at least one species of crude drugs selected from peppermint, chrysanthemum flowers and cicada's shells, a KASHITSU component (a moisturizing component) comprises at least one species of crude drugs selected from talc and Plantago seeds, a KATAN, KAIN component (a component for treating a large amount of phlegm with fever and the like) comprises at least one species of crude drugs selected from seeds of Trichosanthes kirilowii, roots of Trichosanthes kirilowii, Fritillaria verticillata and Pinelliae tuber. The rate of the JIIN component is 5-85 pts.wt. and the rate of a sub-component is 5-80 pts.wt. in the whole components. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本願発明は、漢方処方による花粉症の治療薬に関するものである。   The present invention relates to a therapeutic agent for hay fever by a Chinese medicine prescription.

特開平8−40922号公報JP-A-8-40922

あり余るほどの豊富な食生活、車社会、運動不足、頭を悩ますこと(ストレス)の多い日々、冷暖房の完備、地球の温暖化等、古代に比べると、現代日本における生活情況は大きく変化している。そのため、現代の人々は気欝し、内熱をもちやすく、ひいては、陰を損ない、痰や「お血」を生じ易い。このような状態となった体質を漢方では陰虚体質と呼ぶ。   Living conditions in modern Japan have changed significantly compared to ancient times, such as abundant dietary habits, car society, lack of exercise, stressful days (stress), complete air conditioning, global warming, etc. ing. For this reason, people today are apt to have internal heat and tend to have a fever and “blood”. The constitution that has become such a state is called a negative constitution in Chinese medicine.

ここで、上記の「気欝」とは、漢方思想において、体のエネルギーである「気」のバランスが崩れたことにより現れる、憂欝感、抑欝感、不安感などの症状である。また、「内熱」とは、体を温める力である「陽気」が陰液に比べて相対的に増加することにより体内に生じる熱である。また、「陰」とは体内に存在する体液のことであり、「陰虚」とは、体液が不足して乾燥状態にあることを言う。また、「痰」とは、体液が停滞し煮詰められることによって生じる、病的な産物である。なお、この病理産物のうち、粘りのあるものを「痰」と言い、薄いものを「飲」と言う。なお、このようにして体内の湿気が発病因子となり得る場合、この湿気を「湿邪」と言う。また、「お血」とは血行障害及び血流を逸脱した古い血のことである。   Here, the above-mentioned “Qi” is a symptom such as melancholy, depression, and anxiety that appears when the balance of “Qi”, which is the energy of the body, is lost in Chinese medicine. In addition, “internal heat” is heat generated in the body due to a relative increase in “cheerfulness”, which is a force for warming the body, compared to the negative fluid. “Shade” means a body fluid present in the body, and “shade” means that the body fluid is insufficient and is in a dry state. In addition, “salmon” is a pathological product caused by stagnation and boiling of body fluids. Of these pathological products, the sticky one is called “mochi” and the thin one is called “drink”. In addition, when the moisture in the body can be a pathogenic factor in this way, this moisture is referred to as “humidity”. “Blood” refers to blood circulation disorder and old blood that deviates from the blood flow.

陰虚体質になっても、陰陽失調がある限度を越えるまでは、比較的元気で活動的である。最近の高齢者もほとんどの人々は年齢の割に若く(昔に比べると)、シャキシャキとして活動的である。これも陰虚体質によるものと考える。陰虚体質の人はあえて言うならば、ボクサータイプと言える。   Even if it becomes a negative body, it remains relatively healthy and active until it exceeds a certain limit. Most of the recent elderly are younger than their age (compared to the past) and are active as crisp. This is also thought to be due to the insidious nature. A person with a vulgarity is a boxer type.

臨床においても陰虚の側面をもつ人は非常に多い(発明者の印象では、患者のうちの50〜60%におよぶ)。一方、陰虚の反対である陽虚に属する人は、陰虚に比較して圧倒的に少ない。現在の日本においては、ベースに陰虚の側面をもつ患者の非常に多いということを認識すべきである。   There are very many people who have a negative aspect in the clinic (inventor's impression is 50-60% of patients). On the other hand, the number of people who belong to the positive, which is the opposite of the negative, is overwhelmingly smaller than the negative. It should be recognized that in Japan today, there are a large number of patients with a negative aspect in the base.

古代中国の医学書である「黄帝内経素問」の「四気調神大論」には、「冬三月此謂閉蔵〜此冬気之応養蔵之道也」、「所以聖人春夏養陽、秋冬養陰」、つまり、寒い時期には陰精を養うような生活をすべきであると述べられている。しかし現代においては、夏も冬も同じように生活するため、養陰できず、陰の不足を来たし易い。よって、「内経」的には、冬にあまり活動的に暮らすと陰を養えず陰虚となる可能性が大きいと言える。   In the ancient Chinese medical book “Huang Emperor Kyodo Elementary Question”, “Four Spirits of God”, “Winter March, this so-called closed-this winter Kino-no-Michiya Michiya”, “Holy Saint It is said that you should live a life that feeds your nymphs during cold weather. In modern times, however, they live in the same way in summer and winter, so they can't be nourished. Therefore, it can be said that if you live too actively in winter, it is highly possible that you will not be able to cultivate the shade and become a shame.

以上のことから、現代生活そのものが、まさに陰虚体質の人々を生み出していると言える。ただ、一定陰虚の側面をもつ人の方が活動的で行動も敏捷であり、陰陽失調の程度が限度を越えてしまって発病する迄は、逆説的には、現代生活にむしろ適応し易いと言える。   From the above, it can be said that modern life itself has created people who are truly impatient. However, people with certain negative aspects are more active and more agile, and paradoxically, it is easier to adapt to modern life until the level of yin and yang dysfunction exceeds the limit. It can be said.

陰虚体質の人は内熱(虚熱)を持つ。春になって天の陽気も盛んとなり、冬に比し気温も上昇する(外界の熱)。これにより人体の内熱と外界の熱が呼応し、陰虚内熱が応じてきたところで軽い「風邪」(花粉)の刺激を受け、内熱はますます盛んになり、ついには陽亢化風の状態となって花粉症を発症する。   A person with a negative body has internal heat (virtual heat). In the spring, the sky of heaven becomes brighter and the temperature rises compared to winter (heat from outside). As a result, the internal heat of the human body and the heat of the outside world respond to each other, and when the internal heat of the genus responds, it is stimulated by a light “cold” (pollen), the internal heat becomes more and more intense, and finally the state of positively enhanced wind And hay fever develops.

なお、上記の「風邪」は「ふうじゃ」と読み、一般に言う風邪という病態を指すものではなく、漢方思想で、病気の元となる物質を言う。また、「陽亢」とは体内の「陽気」が上昇すること、「化風」とは、上記の「風邪」によって身体に変化が起こることを言う。   The above-mentioned “cold” is read as “Fuja” and does not refer to the common pathology of cold, but refers to the substance that causes illness in Chinese medicine. In addition, “superiority” means that “cheerfulness” in the body rises, and “formation” means that the above-mentioned “cold” causes changes in the body.

花粉症の症状の中で鼻閉、咽痛、咳、目赤等は、上記の陽亢により引き起こされる。透明な水の如き鼻水は心下(みぞおち)或いは胃にある飲が、陽亢の勢いに乗じて上昇して鼻から溢れたものである。   Among the symptoms of hay fever, nasal congestion, sore throat, cough, redness of the eyes, etc. are caused by the above-mentioned high elevation. A runny nose like clear water is a drink in your heart or stomach that rises with the positive momentum and overflows from your nose.

また、目の痒み、咽の痒み、口中の痒み、鼻の痒み、クシャミ等は化風により引き起こされる。   In addition, itching in the eyes, itching in the throat, itching in the mouth, itching in the nose, crushing, etc. are caused by the breeze.

花粉症において、花粉、つまり「風邪」の存在はその発症のきっかけとしては重要であるが、「風邪」そのものとしては軽微なものである。それよりもむしろ、人体側の陰陽失調の方が病理機序としては重要である。つまり、陰虚内熱の状態が一定のレベルに達してはじめて花粉症を発症するのである。   In hay fever, the presence of pollen, that is, “cold” is important as a trigger for the onset, but “cold” itself is minor. Rather, Yin and Yang imbalance on the human side is more important as a pathological mechanism. In other words, hay fever develops only when the state of the internal heat reaches a certain level.

日本においては、花粉症と言えば、陰虚、陽虚、熱証、寒証にかかわらず「麻黄附子細辛湯」や「小青竜湯」等の処方が、患者に多く投与されている。これらは飲を捌いたり、通竅作用を発揮するため、どのような花粉症に対しても一定の有効性を持っている。なお、「通竅作用」とは、身体に開いた穴の通りを良くすることを言う。しかし、そのほとんどは標治、つまり対症療法にすぎず、その点においては西洋医学における抗アレルギー剤などの投与と変わらない。この様な弁病(病態のみで判断すること)による治療薬の投与は、少なくとも漢方的とは言いがたい。   In Japan, hay fever is often given to patients by prescriptions such as Mao-bushi-shoshin-to and Shosei-ryu, regardless of yin, yang, fever and cold. . These have a certain effectiveness against any hay fever because they drink and have a palliative effect. Note that the “communication effect” means improving the passage of a hole opened in the body. However, most of them are just prescriptions, that is, symptomatic treatments, and in that respect they are no different from administration of antiallergic agents in Western medicine. Administration of a therapeutic drug for such valve disease (judgment based only on the pathological condition) is at least not Kampo.

罹患総数は大変多い花粉症であるが、生死に関わる病いではない。しかし、日常生活に支障をきたしている人にとっては切実な問題である。一般的には、抗アレルギー剤、抗ヒスタミン剤の内服及び局所投与、更にはステロイドの局所投与にて、ほとんどはコントロールされている。しかし、中にはこれらの薬物による治療及びそれに加えて、麻黄附子細辛湯、小青竜湯、辛夷清肺湯等を投与してもコントロールの不良なものもある。これはやはり、このような治療が標治に過ぎないからである。   The total number of affected cases is hay fever, but it is not a life-threatening illness. However, it is a serious problem for people who have trouble with daily life. In general, most are controlled by oral administration and local administration of antiallergic agents and antihistamines, and further by local administration of steroids. However, some of these drugs are poorly controlled even when administered with Mao-bushi-kosho-to, Shoseiryu-to, Shokei-sei-lung-to, etc. in addition to treatment with these drugs. Again, this is because such treatment is only a rule.

上記のことに鑑み、本願発明は、陰虚体質が花粉症を引き起こすことに着目したものである。具体的に、本願発明は、症候及び脈を見極めた上で、陰虚内熱陽亢化風と弁証されるものに対して滋陰、潜陽、清熱、熄風、化風(化湿、化痰、化飲)の治療を行うことで陰虚体質を改善し、有効に花粉症を治療するための、漢方処方による花粉症の治療薬を提供することを課題とする。   In view of the above, the present invention focuses on the fact that the vulgarity causes hay fever. Specifically, the present invention, after identifying the symptoms and the pulse, against what is proved to be a yin-hyeon fever-enhanced wind, It is an object of the present invention to provide a hay fever remedy based on a Kampo prescription for improving the genital constitution by treating vaginosis and chemical drinking, and effectively treating hay fever.

なお、特許文献1に係る発明は、活血作用を有する漢方薬を用いることにより、アレルギー性疾患を引き起こす、人体の過剰対応を抑制する治療薬に関するものである。しかし、陰虚体質を改善するという面から花粉症の治療薬を提供することは、現在までなされていなかったことであり、本願の発明者が初めてなしたものである。   In addition, the invention which concerns on patent document 1 is related with the therapeutic agent which suppresses the excessive response | compatibility of the human body which causes an allergic disease by using the Chinese medicine which has an active blood effect. However, the provision of a hay fever therapeutic agent in terms of improving the vulgarity has not been done so far, and this is the first time the inventor of the present application has made it.

上記課題を解決するために、本願の請求項1に記載の発明は、漢方処方による花粉症の治療薬において、漢方思想における、「陰」を補う効能を有する滋陰成分と、「陽」を抑える効能を有する潜陽成分と、体内の熱を冷ます効能を有する清熱成分と、「陰虚」により引き起こされた身体の諸症状を改善する効能を有する熄風成分と、「湿邪」を体外に排出する効能を有する化湿成分と、体内に発生した「痰」や「飲」により起こる身体の諸症状を改善する効能を有する化痰・化飲成分とのうち、上記の滋陰成分、及び、上記の潜陽成分、清熱成分、熄風成分、化湿成分、化痰・化飲成分のうちから選択された1種以上の成分からなる副成分が、含有成分のうち少なくとも一部を占めるものであり、上記の滋陰成分が、乾地黄、玄参、芍薬、山薬、麦門冬、北沙参、山茱萸、牛膝、から選択された少なくとも1種の生薬から構成されたものであり、潜陽成分が、代赭石、竜骨、牡蛎、から選択された少なくとも1種の生薬から構成されたものであり、清熱成分が、知母、石膏、から選択された少なくとも1種の生薬から構成されたものであり、熄風成分が、薄荷、菊花、蝉退、から選択された少なくとも1種の生薬から構成されたものであり、化湿成分が、滑石、車前子、から選択された少なくとも1種の生薬から構成されたものであり、化痰・化飲成分が、か楼仁、か楼根、貝母、半夏、から選択された少なくとも1種の生薬から構成されたものであって、治療薬の全体中に占める成分の割合について、上記滋陰成分が5〜85重量部、上記副成分が5〜80重量部とされたことを特徴とする、漢方処方による花粉症の治療薬を提供する。   In order to solve the above-mentioned problem, the invention according to claim 1 of the present application provides a therapeutic agent for hay fever by Kampo prescription, a Shi-Yin component having the effect of supplementing “Yin” in the Kampo philosophy, and “Yang”. A latent component that has the effect of suppressing, a clean heat component that has the effect of cooling the heat in the body, a folding screen component that has the effect of ameliorating various symptoms of the body caused by `` collapse '', and `` humidity '' Among the moisturizing ingredients that have the effect of being discharged outside the body, and the above-mentioned moist / ingredient ingredients that are effective in improving various symptoms of the body caused by "salmon" and "drinking" And a sub-component composed of one or more components selected from the above-mentioned latent and positive components, fresh heat components, folding screen components, moisturizing components, and chemical components The above-mentioned ingredients are dry ground yellow, ginseng, glaze, It is composed of at least one herbal medicine selected from medicinal, barley winter, north ginseng, yam, cow knee, and the latent component is at least one selected from metaphorite, keel, oyster It is composed of a variety of herbal medicines, and the fresh heat component is composed of at least one herbal medicine selected from a mother, gypsum, and the folding screen component is a thin load, chrysanthemum, declining It is composed of at least one selected herbal medicine, and the moisturizing component is composed of at least one herbal medicine selected from talc, car anterior, Is composed of at least one kind of herbal medicine selected from karoujin, karou root, shell mother, half-summer, and the ratio of the ingredients in the whole therapeutic drug is Is 5 to 85 parts by weight, and the above-mentioned subcomponent is 5 to 80 parts by weight. And wherein, to provide a therapeutic agent of hay fever due to Chinese medicine prescription.

また、本願の請求項2に記載の発明は、上記の副成分が、上記の潜陽成分、清熱成分、熄風成分、から選択された2種以上の成分からなることを特徴とする、請求項1に記載の、漢方処方による花粉症の治療薬を提供する。   The invention according to claim 2 of the present application is characterized in that the subcomponent is composed of two or more components selected from the latent component, the clean heat component, and the folding screen component. Item 2. A remedy for hay fever according to Kampo prescription according to Item 1.

また、本願の請求項3に記載の発明は、上記の副成分が、上記の潜陽成分、清熱成分、熄風成分、から選択された1種以上の成分、及び、化湿成分、化痰・化飲成分のうちから選択された1種以上の成分からなることを特徴とする、請求項1に記載の、漢方処方による花粉症の治療薬を提供する。   Further, in the invention according to claim 3 of the present application, the subcomponent is at least one component selected from the latent component, the clean heat component, and the folding screen component, and the moisturizing component and the chemical component. The remedy for hay fever according to the Kampo prescription according to claim 1, comprising at least one component selected from chemical ingredients.

本願発明は、「陰」を補う、つまり体内を潤す効能を有する生薬から構成された滋陰成分を主体としたものであって、これを服用することにより陰虚体質を改善し、根本的に花粉症を治療することのできる、漢方処方による花粉症の治療薬を提供することができたものである。   The invention of the present application is made up mainly of a soy-ingredient component made up of herbal medicines that supplements “shade”, that is, has the effect of moisturizing the body. It was possible to provide a medicine for treating hay fever according to Kampo prescription that can treat hay fever.

以下、本願発明の実施の形態の一例を例示して説明する。なお、本例における治療薬の服用は、下記各成分の生薬を煎じ、有効成分を抽出することによってなされる。この有効成分の抽出は、患者自らが行うものとし、患者には生薬をそのまま処方するものとしても良いし、あらかじめ抽出がなされたものとし、患者にはその抽出されたエキス分を処方するものとしても良く、有効成分の抽出手段としては種々の手段が採用できる。   Hereinafter, an example of an embodiment of the present invention will be described as an example. In this example, the therapeutic agent is taken by decocting herbal medicines of the following components and extracting the active ingredients. The extraction of this active ingredient shall be performed by the patient himself, the patient may prescribe herbal medicine as it is, the extraction shall have been made in advance, and the patient shall be prescribed the extracted extract. Various means can be employed as the means for extracting the active ingredient.

なお、本願発明に係る治療薬は、陰虚内熱陽亢化風と弁証された患者に処方されるが、その判断の一つとして脈診が用いられる。具体的には、陰虚内熱陽亢化風の場合、関前の脈が「浮、弦、数」、或いは「浮、弦、細、数」を呈し、かつ、関後の脈が「沈、細、数」(時には「浮」)を呈することが多いので、これを基に判断する。   In addition, although the therapeutic agent based on this invention is prescribed to the patient who was admitted as the pyloric hyperthermia wind, pulse diagnosis is used as one of the judgments. More specifically, in the case of the Yin-Yu-inspired wind, the Sekizen's pulse is “Float, String, Number” or “Float, String, Fine, Number”, and the Sekigo's pulse is “Sink, Thin, , “Number” (sometimes “floating”), and so on.

なお、この脈診は、「寸」「関」「尺」の3部に分けて行われる。図1に示すように、橈骨茎状突起の部位を「関」(A)と言い、この「関」(A)よりも手の側を「寸」(B)、肘の側を「尺」(C)と言う。上記「関前の脈」とは、この「寸」(B)における脈のことを示し、「関後の脈」とは、この「尺」(C)における脈のことを示す。   This pulse diagnosis is performed in three parts, “size”, “seki”, and “scale”. As shown in FIG. 1, the portion of the radial styloid process is referred to as “Seki” (A), the hand side of this “Seki” (A) is “Dimension” (B), and the elbow side is “Scale”. Say (C). The above-mentioned “pulse before Seki” indicates a pulse at this “dimension” (B), and the “pulse after Seki” indicates a pulse at this “scale” (C).

上記の「浮」とは、指を軽く触れただけでわかる脈の状態を指し、「弦」とは、弓の弦に触れるような感じで上下動の少ない突っ張った脈の状態を指し、「数」とは、拍動数の多い脈の状態を指し、「細」とは、幅の狭い脈の状態を指し、「沈」とは、「浮」の反対で指を触れた程度ではわからず、強く圧してわかる脈の状態を指す。   The above `` floating '' refers to the state of a pulse that can be understood by simply touching the finger, and the `` string '' refers to the state of a stretched pulse that feels like touching the bowstring, with little vertical movement, "Number" refers to the state of a pulse with a high number of beats, "Thin" refers to the state of a narrow pulse, and "Sink" refers to the extent to which the finger is touched against "Floating" First, it refers to the state of the pulse that can be understood with strong pressure.

本願発明に係る治療薬は、滋陰成分、及び、上記の潜陽成分、清熱成分、熄風成分、化湿成分、化痰・化飲成分のうちから選択された1種以上の成分からなる副成分が、含有成分のうち少なくとも一部を占めるものとされる。上記の副成分については、患者の症状などに応じて適宜処方される。   The therapeutic agent according to the present invention comprises a shiin-in component and at least one component selected from the above-mentioned latent component, fresh heat component, folding screen component, moisturizing component, and chemical and chemical component. The subcomponent occupies at least a part of the contained components. About said subcomponent, it is prescribed suitably according to a patient's symptom etc.

滋陰成分とは、陰を補う、つまり体内を潤す効能を有する生薬から構成される。具体的には、乾地黄、玄参、芍薬、山薬、麦門冬、北沙参、山茱萸、牛膝、から選択された少なくとも1種の生薬から構成される。   Shiin-yin is composed of herbal medicines that supplement the shade, that is, have the effect of moisturizing the body. Specifically, it is composed of at least one herbal medicine selected from dryland yellow, ginseng, glaze, mountain medicine, barley winter, north ginseng, yam, and cow knee.

潜陽成分とは、内熱の原因となる陽気を抑える効能を有する生薬から構成される。具体的には、代赭石、竜骨、牡蛎、から選択された少なくとも1種の生薬から構成される。   A latent component is comprised from the crude drug which has the effect which suppresses the cheerfulness which causes internal heat. Specifically, it is composed of at least one herbal medicine selected from metazoites, keel, and oysters.

清熱成分とは、内熱を冷ます効能を有する生薬から構成される。具体的には、知母、石膏、から選択された少なくとも1種の生薬から構成される。   The fresh heat component is composed of a herbal medicine that has the effect of cooling the internal heat. Specifically, it is composed of at least one herbal medicine selected from mothers and gypsum.

熄風成分とは、陰虚により引き起こされた身体の諸症状を改善する効能を有する生薬から構成される。具体的には、薄荷、菊花、蝉退、から選択された少なくとも1種の生薬から構成される。   The folding screen component is made up of herbal medicines that have the effect of improving various symptoms of the body caused by the shade. Specifically, it is composed of at least one herbal medicine selected from light load, chrysanthemum flower, and withdrawal.

化湿成分とは、湿邪を体外に排出する効能を有する生薬から構成される。具体的には、滑石、車前子、から選択された少なくとも1種の生薬から構成されたものである。   The moisturizing component is composed of a herbal medicine having an effect of discharging a cold out of the body. Specifically, it is composed of at least one herbal medicine selected from talc and a car anterior element.

化痰・化飲成分とは、体内に発生した痰や飲により起こる身体の諸症状を改善する効能を有する生薬から構成される。具体的には、か楼仁、か楼根、貝母、半夏、から選択された少なくとも1種の生薬から構成される。   The fossilized / drinking ingredient is composed of herbal medicines that have the effect of improving various symptoms of the body caused by wrinkles and drinking occurring in the body. Specifically, it is composed of at least one herbal medicine selected from karojin, karoune, kamika, and semi-summer.

本願発明に係る治療薬の全体中に占める上記成分の割合は、滋陰成分が5〜85(より望ましくは15〜75)重量部、上記副成分が5〜80(より望ましくは10〜75)重量部とされる。   The proportion of the above-mentioned components in the whole therapeutic agent according to the present invention is 5 to 85 parts by weight (more preferably 15 to 75 parts by weight) of the innocuous component, and 5 to 80 (more preferably 10 to 75 parts by weight) of the subcomponents. Parts by weight.

また、上記に挙げた滋陰成分及び副成分以外に属さない生薬も、患者の症状や服用をしやすくするために、適宜配合される。例示すると、生甘草、南沙参、丹参、酸棗仁、柏子仁、竜眼肉、遠志、続断、杜仲、麦芽、大黄、黄耆、柴胡、升麻、熟地黄、牛蒡子、銀花、連翹、牡丹皮であるが、その他種々の生薬を配合することができる。   In addition, herbal medicines that do not belong to the ingredients other than the above-mentioned ingredients and sub-components are also appropriately blended in order to facilitate patient's symptoms and administration. For example, raw licorice, Nansha ginseng, Dansang, acid jinjin, Yuzujin, longan, distant, continuation, Tochu, malt, Daihuang, yellow cocoon, Saiko, Sasa, ripening yellow, gyudon, silver flowers, ream, Although it is peony skin, various other crude drugs can be blended.

以下に、発明者が実際に診察を行い、本願発明に係る治療薬の実施例として処方を行った13の症例について説明する。なお、表1〜表4中の数値は生薬の重量(単位:g)を示す。   Below, thirteen cases in which the inventor has actually examined and prescribed as examples of the therapeutic agent according to the present invention will be described. In addition, the numerical value in Table 1-Table 4 shows the weight (unit: g) of a crude drug.

(症例1)33歳 男 花粉症
第1診:2005.4.5
主な症状:鼻閉、鼻汁、目痒、咽痛、クシャミ、頭がボーッとする、口乾、冷飲、身熱、寝汗
処方:表1の1−1欄の通り

第2診:2005.4.8
主な症状:服薬後約2日で鼻閉と口渇以外の症状消失
処方:表1の1−2欄の通り

第3診:2005.4.12
主な症状:鼻閉と口渇消失
処方:表1の1−3欄の通り(第1診と同処方)

第4診:2005.4.16
主な症状:諸症状消失
処方:表1の1−4欄の通り
(Case 1) 33-year-old male first hay fever: 2005.4.5
Main symptoms: Nasal obstruction, nasal discharge, eyelids, sore throat, sneezing, dry head, dry mouth, cold drink, fever, night sweats prescription: as shown in column 1-1 of Table 1

Second examination: 2005.4.8
Main symptom: Symptom disappearance except nasal congestion and dry mouth about 2 days after taking: As shown in column 1-2 in Table 1

Third examination: 2005.4.12
Main symptoms: Nasal obstruction and dry mouth prescription: As shown in columns 1-3 of Table 1 (same prescription as the first diagnosis)

Fourth examination: 2005.4.16
Main symptoms: Various symptoms disappearance prescription: As shown in columns 1-4 of Table 1

(症例2)71歳 男 花粉症
第1診:2005.4.22
主な症状:鼻汁、鼻閉、咳、目痒、咽のイガイガ感、クシャミ、ふらつき
処方:表1の2−1欄の通り

第2診:2005.5.6
主な症状:服薬後約7日で諸症状消失
処方:表1の2−2欄の通り
(Case 2) 71-year-old male first hay fever: April 22, 2005
Main symptoms: Nasal discharge, nasal congestion, cough, eyelids, muscular sensation in the throat, squeaky, wandering prescription: as per column 2-1 in Table 1

Second diagnosis: 2005.5.6
Main symptoms: About 7 days after taking the drug

(症例3)60歳 女 花粉症
第1診:2005.4.11
主な症状:鼻汁、鼻閉、目痒、咽痒、口乾、冷、頭痛、倦怠感
処方:表1の3−1欄の通り、ただし抗アレルギー剤を併用

第2診:2005.4.18
主な症状:鼻閉は継続、鼻汁、目痒、咽痒は消失、頭痛は改善
処方:表1の3−2欄の通り、ただし抗アレルギー剤を併用

第3診:2005.5.9
主な症状:服薬後約4日で諸症状消失
処方:表1の3−3欄の通り、ただし抗アレルギー剤を併用
(Case 3) 60-year-old female first hay fever: April 1, 2005
Main symptoms: nasal discharge, nasal congestion, eyelids, throat, dry mouth, cold, headache, malaise prescription: as shown in column 3-1 of Table 1, but with antiallergic agent

Second examination: 2005.4.18
Main symptoms: nasal congestion continued, nasal discharge, eyelids, throat disappeared, headache improved Prescription: As shown in column 3-2 of Table 1, but combined with antiallergic agents

Third examination: 2005.5.9
Main symptoms: Approximately 4 days after taking the drug, disappearance of various symptoms Prescription: As shown in column 3-3 of Table 1, but combined with antiallergic agents

Figure 2007210933
Figure 2007210933

(症例4)60歳 女 花粉症
第1診:2005.4.13
主な症状:鼻汁、鼻閉、目痒、咳、咽のイガイガ感、不眠
処方:表2の4−1欄の通り

第2診:2005.4.27
主な症状:鼻汁、咽のイガイガ感、不眠は継続、他の症状改善
処方:表2の4−2欄の通り

第3診:2005.5.16
主な症状:花粉症の症状消失、不眠は改善
処方:表2の4−3欄の通り
(Case 4) 60-year-old female, first pollinosis: 2005.4.13
Main symptoms: nasal discharge, nasal congestion, eyelids, cough, throat muscular sensation, insomnia prescription: as shown in column 4-1 of Table 2

Second examination: 2005.4.27
Main symptoms: nasal discharge, throat sensation of throat, insomnia continued, other symptom improvement prescription: as per column 4-2 in Table 2

Third examination: 2005.5.16
Main symptoms: disappearance of hay fever, insomnia is improved prescription: as shown in column 4-3 in Table 2

(症例5)64歳 女 花粉症
第1診:2005.4.4
主な症状:鼻汁、鼻閉、クシャミ、目痒、咳、咽のイガイガ感、口乾、冷飲、腰痛、身涼、肌水、食欲低下
処方:表2の5−1欄の通り、ただし抗アレルギー剤を併用

第2診:2005.4.25
主な症状:鼻閉、鼻汁、クシャミ、口乾、冷飲は継続、目痒、咳、咽のイガイガ感は改善
処方:表2の5−2欄の通り、ただし抗アレルギー剤を併用

第3診:2005.5.16
主な症状:不眠が現れる、4月末から花粉症の症状は改善、腰痛改善
処方:表2の5−3欄の通り
(Case 5) 64-year-old female first hay fever: April 4.4
Main symptoms: Nasal discharge, nasal congestion, sneezing, eyelids, cough, throat sensation of mouth, dry mouth, cold drink, low back pain, coolness, skin water, decreased appetite prescription: as per column 5-1 in Table 2, but anti Combined with allergic agents

Second examination: 2005.4.25
Main symptoms: nasal congestion, nasal discharge, sneezing, dry mouth, cold drinking continued, eyelids, coughing, throat sensation of throat improved Formulation: as shown in column 5-2 of Table 2, but combined with antiallergic agent

Third examination: 2005.5.16
Main symptoms: Insomnia appears. From the end of April, the symptoms of hay fever have improved, and back pain has been improved.

(症例6)57歳 男 花粉症
第1診:2005.4.18
主な症状:鼻閉、鼻汁、目痒、咽痒、クシャミ、夜間の空咳、身熱
処方:表2の6−1欄の通り

第2診:2005.5.30
服薬後4〜5日で花粉症の症状は消失、身熱は継続
処方:表2の6−2欄の通り
(Case 6) 57-year-old male first hay fever: April 18, 2005
Main symptoms: Nasal congestion, nasal discharge, eyelids, throat, sneezing, night sky cough, body heat prescription: as shown in column 6-1 of Table 2

Second examination: 2005.5.30
The symptoms of hay fever disappeared 4 to 5 days after taking the medicine, and the fever continued. Prescription: as shown in column 6-2 in Table 2

Figure 2007210933
Figure 2007210933

(症例7)28歳 男 花粉症
第1診:2005.4.28
主な症状:鼻閉、鼻汁、目痒、クシャミ、身熱、口乾、冷飲
処方:表3の7−1欄の通り、ただし抗アレルギー剤を併用

第2診:2005. 5.19
主な症状:5月初めに諸症状消失
処方:表3の7−2欄の通り
(Case 7) 28-year-old male first pollinosis: 2005.4.28
Main symptoms: Nasal congestion, nasal discharge, eyelids, sneezing, fever, dry mouth, cold drink prescription: as shown in column 7-1 of Table 3, but with antiallergic agents

Second diagnosis: May 19, 2005
Main symptoms: Various symptoms disappeared at the beginning of May: As per column 7-2 in Table 3

(症例8)69歳 女 花粉症
第1診:2005.4.21
主な症状:鼻汁、鼻閉、鼻痒、目痒、涙、クシャミ、肌水
処方:表3の8−1欄の通り

第2診:2005.5.19
主な症状:5月初めに諸症状消失
(Case 8) 69-year-old woman, first diagnosis of hay fever: 2005.4.21
Main symptoms: Nasal discharge, nasal congestion, nasal mucus, eyelids, tears, sneezing, skin water prescription: as shown in column 8-1 of Table 3

Second examination: 2005.5.19
Main symptoms: Symptoms disappear in early May

(症例9) 43歳 女 花粉症
第1診:2005.4.15
主な症状:鼻閉、鼻汁、目痒、咽痒、咳、クシャミ、胸中不快感、倦怠感、肌水
処方:表3の9−1欄の通り、ただし抗アレルギー剤(点鼻液)を併用

第2診:2005.5.10
主な症状:服薬後4〜5日で花粉症の症状は消失、倦怠感は継続
処方:表3の9−2欄の通り
(Case 9) 43-year-old woman, first pollinosis: 2005.4.15
Main symptoms: Nasal congestion, nasal discharge, eyelids, throat, cough, sneezing, chest discomfort, malaise, skin water prescription: As shown in column 9-1 of Table 3, but with antiallergic agent (nasal drops) Combined use

Second examination: 2005.5.10
Main symptoms: 4-5 days after taking the hay fever symptoms disappeared, fatigue was continued prescription: as shown in column 9-2 in Table 3

(症例10)35歳 女 花粉症、喘息
第1診:2005.4.11
主な症状:鼻汁、鼻閉、目痒、咽痒、咳、クシャミ、胃もたれ、倦怠感、手足尖冷、冷飲、口乾
処方:表3の10−1欄の通り

第2診:2005.4.25
主な症状:咳消失、他の花粉症の症状、胃もたれはやや改善、口乾、冷、夕方身熱
処方:表3の10−2欄の通り

第3診:2005.5.16
服薬後数日で花粉症の症状消失
処方:表3の10−3欄の通り
(Case 10) 35-year-old woman Pollen allergy, first asthma diagnosis: 2005.4.11
Main symptoms: Nasal discharge, nasal congestion, eyelids, throat, cough, sneezing, stomach sag, malaise, limb cold, cold drink, dry mouth prescription: as per column 10-1 in Table 3

Second examination: 2005.4.25
Main symptoms: Cough disappearance, other hay fever symptoms, slightly improved stomach sag, dry mouth, cold, evening body heat prescription: as shown in Table 3, column 10-2

Third examination: 2005.5.16
A few days after taking the hay fever symptom disappearance prescription: according to column 10-3 in Table 3

Figure 2007210933
Figure 2007210933

(症例11) 40歳 女 花粉症、喘息
第1診:2005.6.6
主な症状:鼻汁、鼻閉、クシャミ、目痒、身熱、口乾
処方:表4の11−1欄の通り

第2診:2005.6.20
主な症状:6月12日頃から花粉症の症状消失
処方:表4の11−2欄の通り
(Case 11) 40-year-old woman Pollen allergy, first asthma diagnosis: 2005.6.6
Main symptoms: Nasal discharge, nasal congestion, crushing, eyelids, fever, mouth-drying prescription: As shown in column 11-1 in Table 4

Second examination: 2005.6.20
Main symptoms: From June 12th, hay fever symptoms disappearance prescription: as per column 11-2 in Table 4

(症例12)39歳 女 花粉症
第1診:2005.4.27
主な症状:鼻汁、鼻閉、目痒、咽痒、口乾、手掌の皮膚炎
処方:表4の12−1欄の通り

第2診:2005.5.11
主な症状:花粉症の症状改善、手掌の皮膚炎改善
処方:表4の12−2欄の通り

第3診:2005.6.5
主な症状:花粉症の症状消失
処方:表4の12−3欄の通り
(Case 12) 39-year-old woman, first hay fever: April 27, 2005
Main symptoms: nasal discharge, nasal congestion, eyelids, throat, dry mouth, palm dermatitis prescription: as per column 12-1 in Table 4

Second examination: May 11, 2005
Main symptoms: Improvement of hay fever symptoms, palm dermatitis improvement prescription: As shown in column 12-2 of Table 4

Third examination: 2005.6.5
Main symptoms: Pollen allergy symptom disappearance prescription: As shown in column 4-3 of Table 4

(症例13)80歳 男 花粉症
第1診:2005.6.3
主な症状:クシャミ、鼻汁、鼻閉、目痒、のぼせ
処方:表4の13−1欄の通り

第2診:2005.6.24
主な症状:服薬後2〜3日で花粉症の症状改善、6月10日には消失
(Case 13) 80-year-old male first hay fever: June.
Main symptoms: Kushami, nasal discharge, nasal congestion, eyelids, hot flashes Prescription: As per column 13-1 in Table 4

Second examination: 2005.6.24
Main symptoms: Symptoms of hay fever improved 2 to 3 days after taking, disappeared on June 10

Figure 2007210933
Figure 2007210933

上記のように、本願発明に係る治療薬は、陰虚体質により引き起こされた花粉症に対して有効性を有することが、臨床的に確認できたものである。   As described above, it has been clinically confirmed that the therapeutic agent according to the present invention has effectiveness against hay fever caused by the genital constitution.

脈診を行う部位の説明図である。It is explanatory drawing of the site | part which performs a pulse diagnosis.

符号の説明Explanation of symbols

A 「関」
B 「寸」、関前
C 「尺」、関後
A “Seki”
B “Dimension”, Sekizen C “Scale”, Sekigo

Claims (3)

漢方処方による花粉症の治療薬において、
漢方思想における、「陰」を補う効能を有する滋陰成分と、
「陽」を抑える効能を有する潜陽成分と、
体内の熱を冷ます効能を有する清熱成分と、
「陰虚」により引き起こされた身体の諸症状を改善する効能を有する熄風成分と、
「湿邪」を体外に排出する効能を有する化湿成分と、
体内に発生した「痰」や「飲」により起こる身体の諸症状を改善する効能を有する化痰・化飲成分とのうち、
上記の滋陰成分、及び、上記の潜陽成分、清熱成分、熄風成分、化湿成分、化痰・化飲成分のうちから選択された1種以上の成分からなる副成分が、含有成分のうち少なくとも一部を占めるものであり、
上記の滋陰成分が、乾地黄、玄参、芍薬、山薬、麦門冬、北沙参、山茱萸、牛膝、から選択された少なくとも1種の生薬から構成されたものであり、
潜陽成分が、代赭石、竜骨、牡蛎、から選択された少なくとも1種の生薬から構成されたものであり、
清熱成分が、知母、石膏、から選択された少なくとも1種の生薬から構成されたものであり、
熄風成分が、薄荷、菊花、蝉退、から選択された少なくとも1種の生薬から構成されたものであり、
化湿成分が、滑石、車前子、から選択された少なくとも1種の生薬から構成されたものであり、
化痰・化飲成分が、か楼仁、か楼根、貝母、半夏、から選択された少なくとも1種の生薬から構成されたものであって、
治療薬の全体中に占める成分の割合について、
上記滋陰成分が5〜85重量部、上記副成分が5〜80重量部とされたことを特徴とする、漢方処方による花粉症の治療薬。
In the treatment of hay fever by Kampo prescription,
In the Kampo philosophy, the Shiin-in component that has the effect of supplementing the "yin",
A latent component that has the effect of suppressing "yang", and
A clean heat component that has the effect of cooling the heat in the body,
A folding screen component that has the effect of improving various symptoms of the body caused by "collapse";
A moisturizing component having the effect of discharging "humidness" outside the body,
Among the vaginal and chemical ingredients that have the effect of improving various symptoms of the body caused by `` pox '' and `` drinking '' generated in the body,
A subcomponent composed of one or more components selected from the above-mentioned Shiin and Yin components and the above-mentioned latent components, fresh heat components, folding screen components, moisturizing components, and chemical and chemical components Occupy at least a part of
The above-mentioned ingredients are composed of at least one herbal medicine selected from dryland yellow, ginseng, glaze, mountain medicine, barley winter, north sand ginseng, yam, cow knee,
The latent ingredient is composed of at least one herbal medicine selected from metazoites, keel, oysters,
The fresh heat component is composed of at least one herbal medicine selected from mothers, gypsum,
The folding screen component is composed of at least one herbal medicine selected from light load, chrysanthemum flower, and retreat,
The moisturizing component is composed of at least one herbal medicine selected from talc and car antec;
The chemical and chemical ingredient is composed of at least one herbal medicine selected from karoujin, karoune, kamika, and half-summer,
About the proportion of ingredients in the whole therapeutic drug,
A therapeutic agent for hay fever by Kampo prescription, characterized in that 5 to 85 parts by weight of the above-mentioned ingredients and 5 to 80 parts by weight of the above-mentioned accessory ingredients are used.
上記の副成分が、上記の潜陽成分、清熱成分、熄風成分、から選択された2種以上の成分からなることを特徴とする、請求項1に記載の、漢方処方による花粉症の治療薬。   The said subcomponent consists of 2 or more types of components selected from said latent component, a fresh heat component, and a folding screen component, The treatment of hay fever by the Chinese medicine prescription of Claim 1 characterized by the above-mentioned. medicine. 上記の副成分が、上記の潜陽成分、清熱成分、熄風成分、から選択された1種以上の成分、及び、化湿成分、化痰・化飲成分のうちから選択された1種以上の成分からなることを特徴とする、請求項1に記載の、漢方処方による花粉症の治療薬。   The subcomponent is one or more selected from the above-mentioned latent component, clean heat component, folding screen component, and one or more components selected from the moisturizing component and the chemical and chemical component The remedy for hay fever according to the Kampo prescription according to claim 1, characterized by comprising the following components.
JP2006031908A 2006-02-09 2006-02-09 Therapeutic drug for hay fever by Kampo prescription Expired - Fee Related JP4637030B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006031908A JP4637030B2 (en) 2006-02-09 2006-02-09 Therapeutic drug for hay fever by Kampo prescription

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006031908A JP4637030B2 (en) 2006-02-09 2006-02-09 Therapeutic drug for hay fever by Kampo prescription

Publications (2)

Publication Number Publication Date
JP2007210933A true JP2007210933A (en) 2007-08-23
JP4637030B2 JP4637030B2 (en) 2011-02-23

Family

ID=38489691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006031908A Expired - Fee Related JP4637030B2 (en) 2006-02-09 2006-02-09 Therapeutic drug for hay fever by Kampo prescription

Country Status (1)

Country Link
JP (1) JP4637030B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526366A (en) * 2012-02-21 2012-07-04 简福川 Chinese medicine for treating nephritis
JP2012521413A (en) * 2009-03-23 2012-09-13 ナチュラル エンドテック カンパニー リミテッド Composition for preventing or treating insomnia
CN103223019A (en) * 2013-04-04 2013-07-31 施怀杰 Traditional Chinese medicine for treating rhinitis
CN104096085A (en) * 2014-07-05 2014-10-15 济南伟传信息技术有限公司 Traditional Chinese medicine for treating dizziness
CN104324268A (en) * 2014-11-13 2015-02-04 烟台大木医药技术有限公司 Feed additive for preventing and treating swine high fever syndrome
CN109248269A (en) * 2018-10-29 2019-01-22 袁成业 A kind of traditional Chinese medicine for outer use for treating hyperplasia of mammary glands

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716331B (en) * 2012-06-27 2014-03-05 陈慧婷 Prepared rehmannia root traditional Chinese medicine preparation for treating vertigo and preparation method of preparation
CN106822649A (en) * 2017-03-22 2017-06-13 余君豪 Chinese medicine composition of stifling combining oral treatment kidney-deficiency vertigo and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541115A (en) * 1999-04-01 2002-12-03 フー,グオラング Herbal compositions and uses for treating allergic reactions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541115A (en) * 1999-04-01 2002-12-03 フー,グオラング Herbal compositions and uses for treating allergic reactions

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012521413A (en) * 2009-03-23 2012-09-13 ナチュラル エンドテック カンパニー リミテッド Composition for preventing or treating insomnia
CN102526366A (en) * 2012-02-21 2012-07-04 简福川 Chinese medicine for treating nephritis
CN103223019A (en) * 2013-04-04 2013-07-31 施怀杰 Traditional Chinese medicine for treating rhinitis
CN104096085A (en) * 2014-07-05 2014-10-15 济南伟传信息技术有限公司 Traditional Chinese medicine for treating dizziness
CN104324268A (en) * 2014-11-13 2015-02-04 烟台大木医药技术有限公司 Feed additive for preventing and treating swine high fever syndrome
CN109248269A (en) * 2018-10-29 2019-01-22 袁成业 A kind of traditional Chinese medicine for outer use for treating hyperplasia of mammary glands

Also Published As

Publication number Publication date
JP4637030B2 (en) 2011-02-23

Similar Documents

Publication Publication Date Title
JP4637030B2 (en) Therapeutic drug for hay fever by Kampo prescription
CN103816519A (en) Spleen-strengthening dampness-removing traditional Chinese medicine composition and preparation method thereof
CN101085231A (en) Internal-applied traditional Chinese medicine composition for treating depression
CN103908652A (en) Lavipeditum traditional Chinese medicine for treating insomnia and preparation method thereof
CN103520669A (en) Traditional Chinese medicine for treating phlegm-damp accumulation symptom type chest stuffiness and pains
CN102988897A (en) Traditional Chinese medicine composition for treating depression and preparation method thereof
CN104815232A (en) Traditional Chinese medicine preparation for treating primary pulmonary hypertension and preparation method thereof
CN108969714A (en) A kind of strengthening spleen and tonifying lung ball
CN103479968B (en) Traditional Chinese medicine composition for treating heart-fire flaming acne
CN102698073B (en) Traditional Chinese medicine extract for treating allergic rhinitis
CN102670772B (en) Traditional Chinese medicine for treating allergic rhinitis
CN104547642A (en) Tradtional Chinese medicine composition for treating female fibromyalgia syndromes
CN105106508A (en) Cocklebur fruit allergic rhinitis paste
CN104666910A (en) Traditional Chinese medicine for treating allergic rhinitis
CN101129806A (en) Orally taken traditional Chinese medicine composition for treating melancholia
CN104435653A (en) Traditional Chinese medicine composition for treating functional vomiting
CN104225315A (en) Traditional Chinese medicine composition for treating constipation
CN108524898A (en) It is a kind of to be used to treat drug of seborrhea and preparation method thereof
CN102671052B (en) Chinese medicinal composition for treating Meniere&#39;s syndrome
CN102614478B (en) Preparation method for traditional Chinese medicinal lotion for treating kidney Yin deficiency type ecthyma
CN105998559A (en) Traditional Chinese medicine composition for treating Parkinson&#39;s disease
CN105833091A (en) Traditional Chinese medicine composition for treating diabetes
CN105477469A (en) Traditional Chinese medicine for treating lung-deficiency-related cold type anaphylactic rhinitis and preparation method of traditional Chinese medicine
CN105079346A (en) Magnolia liliflora rhinitis injection
CN104587297A (en) Traditional Chinese medicine capsule for treating scleroderma and preparation method thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090825

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091222

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100315

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100415

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101005

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101005

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101026

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101122

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20191203

Year of fee payment: 9

R150 Certificate of patent or registration of utility model

Ref document number: 4637030

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees